Nov 4 (Reuters) – AstraZeneca made an about $10 billion offer to acquire rare-disease drugmaker Rhythm Pharmaceuticals, the Wall Street Journal reported on Wednesday, citing people familiar with the matter.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Leroy Leo)
Brought to you by www.srnnews.com


